Drugs / Allogeneic Islets of Langerhans
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT00265473 | Nov 2005 → May 2010 | hypoglycemia, type 1 diabetes mellitus | University of Minnesota | Completed | No outcome recorded |
| Phase 1/2 | NCT00286624 | Mar 2003 → Aug 2006 | hypoglycemia, type 1 diabetes mellitus | University of Minnesota | Completed | No outcome recorded |
| Phase 1/2 | NCT00285233 | Sep 2000 → Sep 2004 | hypoglycemia, type 1 diabetes mellitus | University of Minnesota | Completed | No outcome recorded |
| Phase 1/2 | NCT00285194 | Apr 2000 → Jan 2004 | hypoglycemia, type 1 diabetes mellitus | University of Minnesota | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00306098 | Dec 2000 → Jul 2004 | type 1 diabetes mellitus | Rodolfo Alejandro | Completed | No outcome recorded |
| Phase not stated1 trial | ||||||
| — | NCT01606475 | — | end stage renal failure, hypoglycemia, type 1 diabetes mellitus | University of Minnesota | No longer available | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Islets of Langerhans | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00265473 ↗ |
| Known as | islets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00306098 ↗ |
| Modality | Cell therapy | “Islets were isolated from two-layer preserved pancreata, purified, cultured for 2 days; and transplanted into six C-peptide-negative, nonuremic, type 1 diabetic patients with...” PMID 14961992 ↗ Mar 2004 |
| Route | Other | “Intraportal infusion of islets of Langerhans” NCT00265473 ↗ |